PT1948654E - Derivados da 5-amino-4-hidroxi-7-(imidazo[1,2-a] piridin-6-ilmetil)-8-metil-nonamida e compostos relacionados como inibidores da renina para o tratamento da hipertensão - Google Patents
Derivados da 5-amino-4-hidroxi-7-(imidazo[1,2-a] piridin-6-ilmetil)-8-metil-nonamida e compostos relacionados como inibidores da renina para o tratamento da hipertensão Download PDFInfo
- Publication number
- PT1948654E PT1948654E PT06793521T PT06793521T PT1948654E PT 1948654 E PT1948654 E PT 1948654E PT 06793521 T PT06793521 T PT 06793521T PT 06793521 T PT06793521 T PT 06793521T PT 1948654 E PT1948654 E PT 1948654E
- Authority
- PT
- Portugal
- Prior art keywords
- nonamide
- imidazo
- ylmethyl
- pyridin
- hypertension
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH15262005 | 2005-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1948654E true PT1948654E (pt) | 2009-09-28 |
Family
ID=37686018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT06793521T PT1948654E (pt) | 2005-09-17 | 2006-09-14 | Derivados da 5-amino-4-hidroxi-7-(imidazo[1,2-a] piridin-6-ilmetil)-8-metil-nonamida e compostos relacionados como inibidores da renina para o tratamento da hipertensão |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8071651B2 (pt) |
| EP (1) | EP1948654B1 (pt) |
| JP (1) | JP2009507900A (pt) |
| CN (1) | CN101268074B (pt) |
| AR (1) | AR056197A1 (pt) |
| AT (1) | ATE434617T1 (pt) |
| BR (1) | BRPI0617166A2 (pt) |
| CA (1) | CA2622082A1 (pt) |
| DE (1) | DE602006007481D1 (pt) |
| ES (1) | ES2328630T3 (pt) |
| IL (1) | IL190061A0 (pt) |
| PL (1) | PL1948654T3 (pt) |
| PT (1) | PT1948654E (pt) |
| TW (1) | TW200804371A (pt) |
| WO (1) | WO2007031558A1 (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| BRPI0620736A2 (pt) | 2005-12-30 | 2011-12-20 | Novartis Ag | compostos orgánicos |
| TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途 |
| US8084485B2 (en) | 2006-03-31 | 2011-12-27 | Vitae Pharmaceuticals, Inc. | 6-(aminoalkyl)indazoles |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| ES2541107T3 (es) | 2007-06-25 | 2015-07-16 | Novartis Ag | Derivados de N5-(2-etoxietil)-N3-(2-piridinil)-3,5-piperidindicarboxamida para su uso como inhibidores de renina |
| TW200927731A (en) | 2007-09-14 | 2009-07-01 | Ortho Mcneil Janssen Pharm | 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones |
| US9114138B2 (en) | 2007-09-14 | 2015-08-25 | Janssen Pharmaceuticals, Inc. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones |
| EA019085B1 (ru) | 2007-09-14 | 2014-01-30 | Янссен Фармасьютикалз, Инк. | 1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны |
| JP5433582B2 (ja) | 2007-11-14 | 2014-03-05 | ジャンセン ファーマシューティカルズ， インコーポレイテッド． | イミダゾ［１，２−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体の正のアロステリック調節因子としてのその使用 |
| WO2010025890A1 (en) | 2008-09-02 | 2010-03-11 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| EP2163245A1 (en) | 2008-09-10 | 2010-03-17 | Novartis Ag | Renin inhibitors for the treatment of psoriasis |
| AU2009304293B2 (en) | 2008-10-16 | 2012-04-26 | Addex Pharma S.A. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| AU2009319387B2 (en) | 2008-11-28 | 2012-05-10 | Addex Pharma S.A. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| CA2760259C (en) | 2009-05-12 | 2018-05-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| JP5634506B2 (ja) | 2009-05-12 | 2014-12-03 | ジャンセン ファーマシューティカルズ， インコーポレイテッド | １，２，３−トリアゾロ［４，３−ａ］ピリジン誘導体ならびに神経障害および精神障害の治療または予防のためのその使用 |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| ES2552455T3 (es) | 2010-11-08 | 2015-11-30 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
| JP5852665B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| JP5852666B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| WO2015110435A1 (en) | 2014-01-21 | 2015-07-30 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| LT3096790T (lt) | 2014-01-21 | 2019-10-10 | Janssen Pharmaceutica, N.V. | Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY119161A (en) * | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
| US7851634B2 (en) * | 2004-03-19 | 2010-12-14 | Novartis Ag | 5-amino 4-hydroxy-7-(1H-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension |
-
2006
- 2006-09-14 EP EP06793521A patent/EP1948654B1/en not_active Not-in-force
- 2006-09-14 ES ES06793521T patent/ES2328630T3/es active Active
- 2006-09-14 PT PT06793521T patent/PT1948654E/pt unknown
- 2006-09-14 DE DE602006007481T patent/DE602006007481D1/de active Active
- 2006-09-14 PL PL06793521T patent/PL1948654T3/pl unknown
- 2006-09-14 CA CA002622082A patent/CA2622082A1/en not_active Abandoned
- 2006-09-14 AR ARP060104027A patent/AR056197A1/es unknown
- 2006-09-14 BR BRPI0617166-4A patent/BRPI0617166A2/pt not_active IP Right Cessation
- 2006-09-14 JP JP2008530533A patent/JP2009507900A/ja active Pending
- 2006-09-14 US US11/992,132 patent/US8071651B2/en not_active Expired - Fee Related
- 2006-09-14 AT AT06793521T patent/ATE434617T1/de active
- 2006-09-14 CN CN2006800341194A patent/CN101268074B/zh not_active Expired - Fee Related
- 2006-09-14 WO PCT/EP2006/066369 patent/WO2007031558A1/en active Application Filing
- 2006-09-15 TW TW095134222A patent/TW200804371A/zh unknown
-
2008
- 2008-03-10 IL IL190061A patent/IL190061A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8071651B2 (en) | 2011-12-06 |
| CA2622082A1 (en) | 2007-03-22 |
| AR056197A1 (es) | 2007-09-26 |
| IL190061A0 (en) | 2008-08-07 |
| EP1948654B1 (en) | 2009-06-24 |
| US20100063087A1 (en) | 2010-03-11 |
| CN101268074B (zh) | 2011-09-21 |
| PL1948654T3 (pl) | 2009-12-31 |
| TW200804371A (en) | 2008-01-16 |
| ATE434617T1 (de) | 2009-07-15 |
| CN101268074A (zh) | 2008-09-17 |
| WO2007031558A1 (en) | 2007-03-22 |
| DE602006007481D1 (de) | 2009-08-06 |
| ES2328630T3 (es) | 2009-11-16 |
| BRPI0617166A2 (pt) | 2011-07-12 |
| JP2009507900A (ja) | 2009-02-26 |
| EP1948654A1 (en) | 2008-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL190061A0 (en) | 5-amino-4-hydroxy-7-(imidazo[1,2-a]pyridin-6-ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension | |
| IL178100A0 (en) | 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension | |
| HRP20180578T1 (hr) | Pirolo[2,3-b]piridin-4-il-amini i pirolo[2m3-b]pirimidin-4-il-amini kao inhibitori janus kinaze | |
| HK1134486A1 (en) | 4, 5-dihydro- [1, 2, 4] triazolo [4,3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders plk1 45--[124][43- f] | |
| ZA200802998B (en) | Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases | |
| EP1670466A4 (en) | PREPARATION OF 1,6,7-TRISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS | |
| PL1893612T3 (pl) | Pochodne pirolo-[2,3-b]pirydyny jako inhibitory kinazy białkowej | |
| IL193740A0 (en) | PYRIDO [3, 2 - e] PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM | |
| HK1199254A1 (en) | Process for the preparation of aurora kinase inhibitors | |
| IL204693A0 (en) | Imidazo[1, 2 - a] pyrimidine derivatives for the treatment of diseases such as diabetes | |
| IL204720A0 (en) | Imidazo [1, 2 - a] pyridine derivatives useful as alk inhibitors | |
| WO2008058126A3 (en) | Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors | |
| IL183188A0 (en) | Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors | |
| EP1796467A4 (en) | INHIBITORS IMIDAZO {4,5-B} PYRAZINONE PROTEIN KINASES | |
| IL179406A0 (en) | Tetrahydro-imidazo[1,5-a] pyridin derivatives as aldosterone synthase inhibitors | |
| ZA200700384B (en) | Hydantoin derivatives for the treatment of inflammatory disorders | |
| EP1804794A4 (en) | SPIROPIPERIDINE COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| ZA200809796B (en) | Pyrazolo [1,5-A]pyrimidines as CDK inhibitors | |
| EP2142543B8 (en) | Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer | |
| EP2142544B8 (en) | Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer | |
| HK1122808A1 (en) | Preparation and use of tetrahydropyrrolo [3, 2-c]t pyridin-4-one derivatives for treatment of obesitty, psychiatric and neurological disorders | |
| HRP20130793T1 (hr) | Derivati 3-alkil-5-(4-alkil-5-okso-tetrahidrofuran-2-il)pirolidin-2-ona kao meä�uprodukti u sintezi inhibitora renina | |
| HK1122797A1 (en) | Derivatives of pyrido | |
| DK1534707T3 (da) | Substituerede 2,4-dihydropyrrolo[3,4-b]quinolin-9-on-derivater egnede som phosphodiesteraseinhibitorer | |
| IL176824A0 (en) | Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |